Faricimab treat-and-extend approach for neovascular age-related macular degeneration: insights from real-world clinical practice. [PDF]
Ruiz-Medrano J +5 more
europepmc +1 more source
Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]
Itoh K, Negishi M.
europepmc +1 more source
Neovascular age-related macular degeneration complicated by large submacular hemorrhage managed with faricimab monotherapy. [PDF]
Lim J, Cho H, Ramkumar H, Adrean SD.
europepmc +1 more source
Elucidating VEGF Biology: A Journey of Discovery and Clinical Translation [PDF]
Ferrara, Napoleone +2 more
core +1 more source
Intravitreal faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration: short and long-term outcomes and assessment of volume dynamics using an artificial intelligence-based tool. [PDF]
Barbosa M +6 more
europepmc +1 more source
IMPACT OF FARICIMAB VERSUS AFLIBERCEPT ON EPIRETINAL MEMBRANE FORMATION OVER 2 YEARS IN PATIENTS WITH DIABETIC MACULAR EDEMA IN THE PHASE 3 YOSEMITE AND RHINE TRIALS. [PDF]
Jaffe GJ +11 more
europepmc +1 more source
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study. [PDF]
Peto T +17 more
europepmc +1 more source
Progress in the treatment of diabetic macular edema with faricimab: a review. [PDF]
Gao M, Liu C, Zeng Y, Wu X, Duan J.
europepmc +1 more source

